Shanghai - Delayed Quote CNY
Changchun BCHT Biotechnology Co. (688276.SS)
20.29
-0.56
(-2.69%)
At close: 3:00:03 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Wei Kong | GM & Director | -- | -- | 1965 |
| Mr. Zhaofeng Meng | Chief Financial Officer | -- | -- | 1964 |
| Mr. Chunlai Jiang | Executive Deputy GM & Director | -- | -- | 1973 |
| Mr. Zhe Zhang | Board Secretary | -- | -- | 1976 |
| Mr. Bing Yu | Deputy General Manager | -- | -- | 1978 |
| Mr. Dawei Liu | Deputy General Manager | -- | -- | 1972 |
| Mr. Xiaohui Chen | Chief Operating Specialist | -- | -- | -- |
| Ms. Wei Wei | Deputy General Manager | -- | -- | 1970 |
| Mr. Changlin Zhu | Core Technical Staff | -- | -- | 1969 |
Changchun BCHT Biotechnology Co.
No. 138, Zhuoyue Street
Chaoyang District
Changchun, 130103
China
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 1,241
Description
Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. The company's products include live herpes zoster vaccine; live varicella vaccine; live, nasal, and freeze-dried influenza vaccine; and Rabies vaccine (vero cell) for humans. Changchun BCHT Biotechnology Co. Ltd. was founded in 2004 and is based in Changchun, China.
Corporate Governance
Changchun BCHT Biotechnology Co.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
May 24, 2024 at 12:00 AM UTC
Ex-Dividend Date